Investing Profile

Roderick Wong

InvestorVC
RTW Investments, Managing Partner
Photo of Roderick Wong, Managing Partner at RTW Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Business School Network
418 CONNECTIONS
Duke University Network
88 CONNECTIONS
cb
RTW Investments Managing Partner
$10.0M - $50.0M
$25.0M
10
CompanyStageDateRound SizeTotal Raised
Jixing Pharmaceuticals
Series DJan 2024$160M
Series BJul 2021
$160M
Milestone Pharmaceuticals
Post Ipo DebtMar 2023$130M
Series DOct 2018$80M
$290M
Co-investors: Debra K. Liebert (Domain Associates), Ela Borenstein (BDC Venture Capital), Eric Linsley (Mission BioCapital), Marco Boorsma (Forbion)
Oricell Therapeutics
Series BFeb 2023$45M
$170M
Co-investors: William Hu (Qiming Venture Partners)
Orchestra BioMed
Series DJan 2022$110M
$110M
NiKang Therapeutics
Series CMay 2021$200M
Series BSep 2020$50M
$250M
Tenaya Therapeutics
Series CMar 2021$110M
$200M
Co-investors: Anthony Philippakis (GV (Google Ventures))
Stoke Therapeutics
Series BOct 2018$90M
$90M
Portfolio Manager Davidson Kempner Capital Management2005 - 2009
Analyst Sigma Capital2004 - 2005
Research Associate Cowen and Company2003 - 2003
Duke University BS Economics
Harvard Business School MBA
University of Pennsylvania School of Medicine MD